Epitalon

Anisimov et al. (Biogerontology): Extends lifespan in multiple animal models by 10-15% via telomerase activation and melatonin regulation.

Khavinson et al. demonstrate Epitalon activates telomerase catalytic subunit (hTERT) expression in human fetal fibroblasts, extending replicative lifespan by 10 population doublings.

Comprehensive 25-year review of Epitalon's antioxidant, neuroprotective, antimutagenic, and anti-cancer properties across in vitro, in vivo, and in silico models.

Korkushko et al.: Epithalamin administration normalizes melatonin production and circadian rhythm in elderly patients, improving sleep and immune function.

Therapeutic peptides offer mechanistically diverse approaches to targeting fundamental hallmarks of aging, a 2026 review demonstrated. While FDA-approved agents show clinical potential, investigational peptides require rigorous validation through well-designed trials to establish long-term safety and efficacy.

Therapeutic peptides, including BPC-157 and TB-500, were found to modulate molecular signaling networks influencing tissue regeneration and inflammation resolution in a 2026 review. The research highlighted their mechanistic potential for orthopaedic applications, noting a current lack of clinical trials.

Epitalon demonstrated dose-dependent telomere length extension in normal human cells through hTERT and telomerase upregulation in a 2025 in-vitro study. Researchers also found that the peptide increased telomere length in cancer cell lines primarily via Alternative Lengthening of Telomeres activation.

The tetrapeptide Epitalon restored delayed wound healing in high glucose-injured human retinal cells by inhibiting epithelial-mesenchymal transition and fibrosis, a 2025 in vitro study demonstrated. Researchers found that the peptide also reduced intracellular reactive oxygen species and restored antioxidant gene expression.

A 2025 review found that the tetrapeptide Epitalon demonstrates geroprotective and neuroendocrine properties through antioxidant and neuroprotective mechanisms. Researchers highlighted its ability to influence melatonin synthesis, modulate interleukin-2 levels, and enhance telomerase activity in preclinical models.

A 2025 preclinical study demonstrated that Epitalon activates telomerase, significantly improving bovine oocyte maturation rates and post-thawed embryo development. The peptide enhanced the overall quality of in vitro mature oocytes and blastocysts by improving mitochondrial health and reducing reactive oxygen species.